A Day in the Life of a CVAD.

J Infus Nurs

Nebraska Antimicrobial Stewardship Assessment and Promotion Program, Nebraska Infection Control Assessment and Promotion Program, and Nebraska Medicine, Omaha, Nebraska (Dr Nailon); Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska (Dr Rupp); and College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska (Ms Lyden). Regina E. Nailon, PhD, RN, facilitates interprofessional research and meaningful use of data in clinical decision making at Nebraska Medicine. Her primary research focus is aimed at improving health outcomes and the infrastructure necessary for the delivery of safe and appropriate care across the care continuum. Mark E. Rupp, MD, is professor and chief of the Division of Infectious Diseases at the University of Nebraska Medical Center. He is also the medical director of the Department of Infection Control and Epidemiology. Dr Rupp studies device-associated infections, staphylococcal disease, and antimicrobial stewardship. Elizabeth Lyden, MS, is associate director of the Center for Collaboration on Research, Design and Analysis, and an instructor in the Department of Biostatistics at the University of Nebraska Medical Center. She provides consultation, data analysis, and manuscript preparation in multiple departments including infectious diseases.

Published: May 2019

Patients are increasingly receiving therapy at home via central vascular access devices (CVADs). Limited data exist regarding patients' experiences with outpatient CVADs. This study characterized outpatient CVAD care via 14-day patient diaries. Information included location, frequency, and purpose of CVAD access episodes and who performed CVAD care. Across all patients, 77% of care was provided in the patient's home compared with other sites. Home care was provided via self-care (48%), by a family member/caregiver (25%), or by a nurse (27%). Flushing the device was the most frequent reason for device access (52%). An occlusion rate of 9.57 per 1000 device days was also noted. Further examination of CVAD maintenance and patient/care provider education is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NAN.0000000000000321DOI Listing

Publication Analysis

Top Keywords

cvad care
8
care provided
8
cvad
5
day life
4
life cvad
4
cvad patients
4
patients increasingly
4
increasingly receiving
4
receiving therapy
4
therapy central
4

Similar Publications

Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomized controlled trial.

J Thromb Haemost

November 2024

School of Medicine, University of Queensland, Brisbane, Australia; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.

Background: Catheter-related thrombosis (CRT) is a complication of central venous access devices (CVADs). Evidence is variable regarding the significance of the side of catheter insertion. The role of the patient's hand dominance in predisposition to CRT remains uncertain.

View Article and Find Full Text PDF

Background: Central line-associated bloodstream infections (CLABSI) increase morbidity, mortality, and healthcare costs. Central venous access device (CVAD) dressing integrity is critical to prevent CLABSI. From the First Quarter to the Third Quarter of 2023, CLABSI rates related to disruption in CVAD dressing integrity increased significantly at our facility.

View Article and Find Full Text PDF

Patient Blood Management: Mixing Versus Discard Methods for Central Venous Catheter Blood Specimen Collection.

J Infus Nurs

November 2024

Author Affiliations: Oncology and Infusion Services, Providence Regional Medical Center Everett Cancer Partnership, Everett, Washington (Sarver); Sarver Better Living Products LLC, Everett, Washington (Sarver); Outpatient Infusion Center, University of Washington Medical Center, Seattle, Washington (McManus); Nursing Services, Medical Oncology, Providence Regional Medical Center Everett, Everett, Washington (Toler); Everett Community College, Everett, Washington (Toler); Providence Regional Medical Center Everett, Everett, Washington (Johnson).

A quasi-experimental study comparing the mixing and discard methods of laboratory specimen techniques in an adult acute care setting was conducted over a 30-month period. Primary end points were delta hemoglobin (Hgb) and transfusion rates. Secondary end points were redraws related to hemolysis and erroneous results, noting central venous access device (CVAD) type.

View Article and Find Full Text PDF

Background: Several studies have upheld the advantages of blood collection using via central venous access device (CVAD); the procedure has a high success rate and avoids painful repeated punctures. Some studies have suggested that via central venous access device (CVAD) blood collection is preferable for acute and critical care, oncology, and pediatric patients. However, there is no consensus on or standardization of this approach.

View Article and Find Full Text PDF

Background: Most children with cancer will require a central venous access device (CVAD) to administer cancer treatment. A commonly used CVAD is a tunnelled cuffed centrally inserted central catheter (TC-CICC). There is little information available to guide best practice when removing this type of CVAD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!